SANTINI, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.852
EU - Europa 12.761
AS - Asia 11.990
SA - Sud America 1.504
AF - Africa 323
Continente sconosciuto - Info sul continente non disponibili 60
OC - Oceania 43
Totale 53.533
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.788
CN - Cina 4.902
SG - Singapore 3.351
IT - Italia 3.064
RU - Federazione Russa 2.848
BR - Brasile 1.220
DE - Germania 1.172
HK - Hong Kong 1.082
UA - Ucraina 934
PL - Polonia 912
CA - Canada 899
FR - Francia 872
VN - Vietnam 813
GB - Regno Unito 795
SE - Svezia 761
FI - Finlandia 545
TR - Turchia 378
KR - Corea 353
IN - India 241
IE - Irlanda 212
ZA - Sudafrica 168
NL - Olanda 147
JP - Giappone 141
BD - Bangladesh 138
MX - Messico 109
ES - Italia 94
AR - Argentina 84
IQ - Iraq 63
IR - Iran 62
PK - Pakistan 61
EU - Europa 59
UY - Uruguay 57
BE - Belgio 56
CZ - Repubblica Ceca 48
CH - Svizzera 47
MY - Malesia 45
PT - Portogallo 41
RO - Romania 41
ID - Indonesia 39
TH - Thailandia 39
AT - Austria 37
AM - Armenia 35
TW - Taiwan 35
AU - Australia 34
CL - Cile 33
LT - Lituania 33
EG - Egitto 30
NG - Nigeria 29
UZ - Uzbekistan 28
EC - Ecuador 24
VE - Venezuela 24
IL - Israele 22
AE - Emirati Arabi Uniti 21
MA - Marocco 20
HU - Ungheria 19
KE - Kenya 19
PE - Perù 19
CO - Colombia 18
SA - Arabia Saudita 18
JO - Giordania 17
NP - Nepal 17
PH - Filippine 17
PY - Paraguay 15
TN - Tunisia 15
AZ - Azerbaigian 14
JM - Giamaica 13
DZ - Algeria 11
SK - Slovacchia (Repubblica Slovacca) 10
HN - Honduras 9
HR - Croazia 9
KG - Kirghizistan 9
BG - Bulgaria 8
LK - Sri Lanka 8
AL - Albania 7
NZ - Nuova Zelanda 7
PA - Panama 7
PS - Palestinian Territory 7
RS - Serbia 7
BO - Bolivia 6
GR - Grecia 6
SN - Senegal 6
CR - Costa Rica 5
DK - Danimarca 5
KH - Cambogia 5
KZ - Kazakistan 5
LU - Lussemburgo 5
MK - Macedonia 5
OM - Oman 5
LB - Libano 4
NI - Nicaragua 4
NO - Norvegia 4
AO - Angola 3
BW - Botswana 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GA - Gabon 3
LV - Lettonia 3
MT - Malta 3
PR - Porto Rico 3
Totale 53.478
Salva come PNG Salva come JPEG
Città #
Jacksonville 2.159
Ashburn 2.137
Woodbridge 1.974
Fairfield 1.890
Singapore 1.633
San Jose 1.431
Chandler 1.265
Houston 1.191
Hong Kong 1.032
Wilmington 990
Boardman 946
Ann Arbor 827
Seattle 819
Beijing 800
Dearborn 757
Nanjing 696
Cambridge 607
Toronto 586
Warsaw 540
Camerino 496
The Dalles 455
Los Angeles 444
San Mateo 351
Kraków 344
Seoul 327
New York 323
Tongling 315
Council Bluffs 311
Princeton 309
Lawrence 306
Columbus 299
Helsinki 286
Istanbul 285
Lauterbourg 269
Ho Chi Minh City 242
Ogden 238
Nanchang 225
Dallas 214
Dublin 207
Hanoi 203
Buffalo 198
Bremen 193
Rome 183
Chicago 177
Milan 174
Moscow 166
London 165
Shenyang 155
Lachine 154
Kunming 150
St Louis 142
Santa Clara 140
Shanghai 140
Guangzhou 136
Johannesburg 135
São Paulo 127
Orem 115
Jiaxing 111
Tianjin 102
Tokyo 102
Munich 97
Trieste 96
San Diego 91
Hebei 87
Düsseldorf 85
Changsha 79
Frankfurt am Main 77
Redwood City 76
Jinan 72
Hefei 71
Brooklyn 64
Montreal 64
Wuhan 64
Chennai 63
Hangzhou 63
Montevideo 56
Denver 55
Manchester 54
Salt Lake City 52
Atlanta 51
Phoenix 50
Mexico City 49
Redondo Beach 49
Zhengzhou 49
Philadelphia 48
San Francisco 48
Verona 46
Falls Church 44
Venezia 44
Brussels 43
Dong Ket 43
Rio de Janeiro 43
Stockholm 43
Da Nang 42
Orange 41
Ascoli Piceno 39
Boston 39
Haiphong 38
Jinhua 36
Belo Horizonte 35
Totale 33.980
Salva come PNG Salva come JPEG
Nome #
Additivi inorganici ritardanti di fiamma non alogenati: idrossido di magnesio naturale ed idrossido di alluminio prodotti per macinazione 688
Functionalized gold nanorods as drug carriers: a promising antiviral system 389
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 332
XLIII Congresso Nazionale di Chimica Inorganica 326
Novel metalloantimalarials: Transmission blocking effects of water soluble Cu(I), Ag(I) and Au(I) phosphane complexes on the murine malaria parasite Plasmodium berghei 299
Novel triazolium based 11th group NHCs: synthesis, characterization and cellular response mechanisms 294
Boron-Centered Scorpionate-Type NHC-Based Ligands and Their Metal Complexes 293
Chemistry and relevant biomimetic applications of group 6 metals systems supported by scorpionates 290
The hydridotris(3-nitro-1,2,4-triazol-1-yl)borate, a new nitro-substituted electron withdrawing polydentate "scorpionate"-type ligand and related copper and silver phosphane complexes 282
Synthesis and properties of poly(pyrazolyl)borate and related boron-centered scorpionate ligands. Part A: pyrazole-based systems 267
Syntheses and Biological Studies of Cu(II) Complexes Bearing Bis(pyrazol-1-yl)- and Bis(triazol-1-yl)-acetato Heteroscorpionate Ligands 264
Novel antitumor copper(ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity 263
Copper(I) isocyanide and phosphane complexes of fluorinated mono- and bis-(pyrazolyl)borates 262
Insights into the cytotoxic activity of the phosphane copper(I) complex [Cu(thp)4][PF6] 261
Exploring fluorinated and non-fluorinated β-diketonates: synthesis and biological evaluation of first-row transition metal(II) complexes for cancer treatment 253
null 248
Advances in Copper Complexes as Anticancer Agents 245
Scorpionate complexes with the main group elements Ca, Ba, Sr 241
Scorpionates bearing nitro substituents: mono-, bis- and tris-(3-nitro-pyrazol-1-yl)borate ligands and their copper(I) complexes 237
Electrospray ionization multi-stage mass spectrometric study of the interaction products of the cytotoxic complex [Cu(thp)4][PF6] with methionine-rich model peptides 237
Synthesis, in vitro and in vivo characterization of Cu-64(I) complexes derived from hydrophilic tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane ligands 236
A new ester substituted heteroscorpionate ligand 236
Synthesis and properties of poly(pyrazolyl)borate and related boron-centered scorpionate ligands. Part B: imidazole-, triazole- and other heterocycle-based systems 235
Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies 235
National Science Centre (NCN) of Poland. OPUS 12: general grants. 235
Solution and solid-state structural properties of silver(I) dihydrobis(pyrazolyl)borate compounds with tertiary mono(phosphine) ligands 231
Copper(I)-organophosphine complexes of bis(3,5-dimethylpyrazol-1-yl) dithioacetate ligand 230
11th workshop on PharmacoBioMetallics (BIOMET11) 229
Oxo-rhenium(V) compounds containing bis(3,5-dimethylpyrazol-1-yl)acetate scorpionate ligand 229
Dalle fosfine ai carbeni idrosolubili: sviluppo di complessi del gruppo 11 e studi bioinorganici 226
A Study on the Coordinative Versatility of new N,S-donor Macrocyclic Ligands: XAFS, and Cu2+ complexation thermodynamics in solution 224
3rd INTERNATIONAL SCHOOL OF ORGANOMETALLIC CHEMISTRY “LIGANDS IN ORGANOMETALLIC CHEMISTRY: TRADITION AND INNOVATION” 220
B - The Romanian National Council for Scientific Research (CNCS) though Executive Agency for Higher Education, Research, Development and Innovation Funding, (UEFISCDI). PNCDI III - Programme 2 - Subprogramme 2.1. Competitiveness by research, development and innovation. Experimental Demonstrative Projects (PED 2016). 220
ACS Petroleum Research Fund Grant Programs - USA 220
Silver(I) and copper(I) complexes supported by fully fluorinated 1,3,5-triazapentadienyl ligands 218
FWF Austrian Science Fund (Stand-Alone Projects) 218
[M(HB(pz)3)(P)] complexes (P = monodentate phosphine): comparison of the antiproliferative activity of silver and copper “3+1” mixed-ligand compounds 217
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 216
[Cu(thp)4][PF6] as an Effective Therapeutic Agent for the Treatment of Solid Tumors, including Refractory Tumors 214
Synthesis, spectroscopic characterization, and structural systematics of new triorganophosphinecopper(I) poly(pyrazol-1-yl)borate complexes 213
In Vitro Antitumour Activity of Water Soluble Cu(I), Ag(I) and Au(I) Complexes Supported by Hydrophilic Alkyl Phosphine Ligands 213
Realizzazione del sito web e webmaster del XLIII Congresso Nazionale di Chimica Inorganica 213
Highly Hydrophilic Gold Nanoparticles as Carrier for Anticancer Copper(I) Complexes: Loading and Release Studies for Biomedical Applications 211
Recent Advances in Medicinal Applications of Coinage-Metal (Cu and Ag) N-Heterocyclic Carbene Complexes 210
C - The Romanian National Council for Scientific Research (CNCS) though Executive Agency for Higher Education, Research, Development and Innovation Funding, (UEFISCDI). PNCDI III - Programme 2 - Subprogramme 2.1. Competitiveness by research, development and innovation. Experimental Demonstrative Projects (PED 2016). 210
Novel multicharged silver(I)–NHC complexes derived from zwitterionic 1,3-symmetrically and 1,3-unsymmetrically substituted imidazoles and benzimidazoles: Synthesis and cytotoxic properties 210
New volatile polyazolylborates of copper(I) for MOCVD 209
Trinuclear copper(I) complexes with triscarbene ligands: catalysis of C-N and C-C coupling reactions 209
4th INTERNATIONAL SCHOOL OF ORGANOMETALLIC CHEMISTRY “RELEVANCE OF BASIC RESEARCH TO APPLICATIONS IN ORGANOMETALLIC CHEMISTRY” 208
In vitro activity and neurotoxicity of new promising metal-based anticancer complexes 207
Design, Synthesis and Biological Evaluation of Novel Chemical Entities as Potential Anticancer Drugs and for the Control of the Metastatic Process 206
Neutral and charged phosphine/scorpionate copper(I) complexes: Effects of ligand assembly on their antiproliferative activity 206
Synthesis and in vitro antitumor activity of water soluble sulfonate- and ester-functionalized silver(I) N-heterocyclic carbene complexes 206
Standard projects of the Czech Science Foundation (in Czech “Grantová agentura České republiky – GACR”) or Czech Health Research Council (in Czech “Agentura pro zdravotnický výzkum České republiky – AZV”) established by Ministry of Health of the Czech Republic. 206
Bridged poly(1-imidazolyl)borate silver(I) complexes containing tertiary mono(phosphine) ligands. The first structurally authenticated bis(imidazolyl)borate metal complex 205
Silver(I) and gold(I) complexes of hydrotris(3,5-dimethylpyrazol-1-yl)borate: synthesis, spectroscopic and structural characterization, and reactivity toward C-, N- and S-donor ligands 204
New insights in Au-NHCs complexes as anticancer agents 204
Synthesis and spectroscopic characterization of new triorganotin(IV) complexes with the bis(1-methyl-1H-imidazol-2-ylthio)acetate ligand: effects on trout erythrocyte components 204
Synthesis, characterization and antioxidant activity of new copper(I) complexes of scorpionate and water soluble phosphane ligands 203
[Cu(thp)4][PF6] as an effective therapeutic agent for the treatment of solid tumors, including refractory tumors 203
Synthesis, characterization and crystal structure of new copper(II) complexes with tris- and tetrakis-(pyrazol-1-yl)borate ligands 201
Synthesis and spectroscopic characterization of new organotin(IV) complexes with bis(3,5-dimethylpyrazol-1-yl)dithioacetate 200
Novel scorpionate-type triscarbene ligands and their silver and gold complexes 199
Variable co-ordination numbers in 1:1 adducts of silver(I) tetrakis(pyrazolyl)borates with tertiary phosphines 199
Complessi di rame(I) con leganti tris(azolil)borati e fosfine monodentate: sintesi e studi biologici 199
Silver(I) poly(1,2,3-benzotriazolyl)borate complexes containing mono- and bidentate phosphine coligands 198
Structure and volatility of copper complexes containing pyrazolyl-based ligands 198
Polypyrazolylborate and Scorpionate Ligands 197
In vitro antitumor activity of the water soluble copper(I) complexes bearing tris(hydroxymethyl)phosphine ligand 197
Applications of scorpionate ligands in enzyme modeling and biological studies 196
Metal systems supported by Scorpionates 196
Synthesis and cytotoxic activity evaluation of new Cu(I) complexes of bis(pyrazol-1-yl) acetate ligands functionalized with an NMDA receptor antagonist 196
Synthesis and solution studies by electrospray mass spectroscopy of new bis(imidazolyl)borate organotin(IV) complexes 195
New (diphenylphosphane)benzoic acid copper(I) derivatives of “scorpionate” ligands with superoxide scavenging activity 195
Trichloro-, mono-, di- and tri-organotin(IV) derivatives of hydridotris(4-methylpyrazol-1-yl)borates. 194
Biomimetic Applications of Metal Systems Supported by Scorpionates 194
Copper and Silver Derivatives of Scorpionates and related Ligands 194
The relationship between electrospray ionization behavior and cytotoxic activity of [MI(P)4]+-type complexes (M = Cu, Ag and Au; P = tertiary phosphine) 194
Atti del Congresso XLIII Congresso Nazionale di Chimica Inorganica 194
Synthesis, characterization and hydrolytic behavior of new bis(2-pyridylthio)acetate ligand and related organotin(IV) complexes 193
2nd INTERNATIONAL SCHOOL OF ORGANOMETALLIC CHEMISTRY “p-BONDING HYDROCARBON SYSTEMS AND METALS” 192
Copper in Diseases and Treatments, and Copper-based Anticancer Strategies 192
[Cu(thp)4][X] compounds for the treatment of a broad range of human solid tumors, including refractory tumors 191
Tris(4-bromo-1H-pyrazol-1-yl)borato derivatives of first-row transition and group 12 and 14 metals. X-ray crystal structure of [HB(4-Brpz)3]2Cd. 113Cd solution NMR study of bis[poly(pyrazolyl)borato]cadmium complexes 190
Development of new and efficient copper(II) complexes of hexyl bis(pyrazolyl)acetate ligands as catalysts for allylic oxidation 190
New homoleptic carbene transfer ligands and related coinage metal complexes 189
Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand 189
Novel hydrophilic Au(I) and Ag(I) NHCs complexes 189
Synthesis and structural studies of a 1 : 2 adduct of silver(I) tetrakis(pyrazolyl)borate(III) with a tertiary phosphine 189
Rational design and biological evaluation of novel conjugated heteroscorpionate ligands and related Copper(I/II) complexes 189
From phoshines to carbens: synthesis of new coinage metal complexes with applications in bioinorganic chemistry 188
The reactivity of hydrotris(3-methyl-2-thioxo-1-imidazolyl)borate (Tm) towards organotin(IV) acceptors. An unprecedented monodentate coordination mode of Tm ligand 187
Unsymmetrical 3- and 5-substituted bis(pyrazolyl)borate system 187
XAFS studies on copper(I) complexes containing scorpionate ligands 186
Synthesis and characterization of new copper(I) complexes containing 4-(diphenylphosphane)benzoic acid and "scorpionate" ligands with "in vitro" superoxide scavenging activity 186
Di- and tri-organotin(IV) complexes of the new bis(1-methyl-1H-imidazol-2-ylthio) acetate ligand and the decarboxylated analogues 186
[Cu(thp)4]n[X]-n Compounds for the Treatment of a Broad Range of Human Solid Tumors, Including Refractory Tumors 185
New zwitterionic mono-NHC ligands and related hydrophilic Au(I), Ag(I) and Cu(I) carbene complexes 185
Coordination chemistry of the sterically hindered N3-donor hydrotris (3,5-diphenylpyrazol-1-yl) borate toward silver(I) triorganophosphino compounds. Synthesis, structural and spectroscopic characterization 185
Leganti eteroscorpionati bio-coniugati e relativi complessi di Cu(II): sintesi, attività biologica e studi XAS 184
Totale 22.308
Salva come PNG Salva come JPEG
Categoria #
all - tutte 229.237
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 229.237
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021514 0 0 0 0 0 0 0 0 0 0 0 514
2021/20223.139 276 853 59 88 233 128 106 250 234 326 246 340
2022/20233.837 364 48 117 538 536 558 19 253 782 194 285 143
2023/20243.345 475 178 287 106 172 334 121 191 393 99 86 903
2024/202510.190 404 246 963 578 379 501 967 2.326 768 777 794 1.487
2025/202613.688 866 890 1.058 1.953 1.484 1.016 2.419 985 744 1.033 904 336
Totale 54.439